BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25264323)

  • 1. Protected hinge in the immunoglobulin G2-A2 disulfide isoform.
    Liu YD; Chou RY; Dillon TM; Poppe L; Spahr C; Shi SD; Flynn GC
    Protein Sci; 2014 Dec; 23(12):1753-64. PubMed ID: 25264323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational difference in human IgG2 disulfide isoforms revealed by hydrogen/deuterium exchange mass spectrometry.
    Zhang A; Fang J; Chou RY; Bondarenko PV; Zhang Z
    Biochemistry; 2015 Mar; 54(10):1956-62. PubMed ID: 25730439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG2 disulfide isoform conversion kinetics.
    Liu YD; Wang T; Chou R; Chen L; Kannan G; Stevenson R; Goetze AM; Jiang XG; Huang G; Dillon TM; Flynn GC
    Mol Immunol; 2013 Jun; 54(2):217-26. PubMed ID: 23291144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human IgG2 antibodies display disulfide-mediated structural isoforms.
    Wypych J; Li M; Guo A; Zhang Z; Martinez T; Allen MJ; Fodor S; Kelner DN; Flynn GC; Liu YD; Bondarenko PV; Ricci MS; Dillon TM; Balland A
    J Biol Chem; 2008 Jun; 283(23):16194-205. PubMed ID: 18339624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Fab-hinge disulfide connectivity in structural isoforms of a recombinant human immunoglobulin G2 antibody.
    Zhang B; Harder AG; Connelly HM; Maheu LL; Cockrill SL
    Anal Chem; 2010 Feb; 82(3):1090-9. PubMed ID: 20039682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfide connectivity of human immunoglobulin G2 structural isoforms.
    Martinez T; Guo A; Allen MJ; Han M; Pace D; Jones J; Gillespie R; Ketchem RR; Zhang Y; Balland A
    Biochemistry; 2008 Jul; 47(28):7496-508. PubMed ID: 18549248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfide scrambling in IgG2 monoclonal antibodies: insights from molecular dynamics simulations.
    Wang X; Kumar S; Singh SK
    Pharm Res; 2011 Dec; 28(12):3128-44. PubMed ID: 21671135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional characterization of disulfide isoforms of the human IgG2 subclass.
    Dillon TM; Ricci MS; Vezina C; Flynn GC; Liu YD; Rehder DS; Plant M; Henkle B; Li Y; Deechongkit S; Varnum B; Wypych J; Balland A; Bondarenko PV
    J Biol Chem; 2008 Jun; 283(23):16206-15. PubMed ID: 18339626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid, automated characterization of disulfide bond scrambling and IgG2 isoform determination.
    Resemann A; Liu-Shin L; Tremintin G; Malhotra A; Fung A; Wang F; Ratnaswamy G; Suckau D
    MAbs; 2018; 10(8):1200-1213. PubMed ID: 30277844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates.
    Liu-Shin L; Fung A; Malhotra A; Ratnaswamy G
    MAbs; 2018; 10(4):583-595. PubMed ID: 29436897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of disulfide linkages at the hinge region of IgG antibodies by HPLC mass spectrometry.
    You J; Shi Y; Zhu W; Wu Z; Xiong J
    Biomed Chromatogr; 2018 Dec; 32(12):e4371. PubMed ID: 30121965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cysteine related variants in an IgG2 antibody by LC-MS with an automated data analysis approach.
    Zhang Y; Bailey R; Nightlinger N; Gillespie A; Balland A; Rogers R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 997():30-7. PubMed ID: 26079266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function.
    Liu H; May K
    MAbs; 2012; 4(1):17-23. PubMed ID: 22327427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Fc receptor-like 5 distinguishes IgG2 disulfide isoforms and deamidated charge variants.
    Alabi O; Dement-Brown J; Tolnay M
    Mol Immunol; 2017 Dec; 92():161-168. PubMed ID: 29101848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of disulfide bond scrambling during production of an antibody-drug conjugate.
    Liu-Shin LP; Fung A; Malhotra A; Ratnaswamy G
    MAbs; 2018; 10(8):1190-1199. PubMed ID: 30339473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrachain disulfide bond in the core hinge region of human IgG4.
    Bloom JW; Madanat MS; Marriott D; Wong T; Chan SY
    Protein Sci; 1997 Feb; 6(2):407-15. PubMed ID: 9041643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interchain disulfide bonding in human IgG2 antibodies probed by site-directed mutagenesis.
    Allen MJ; Guo A; Martinez T; Han M; Flynn GC; Wypych J; Liu YD; Shen WD; Dillon TM; Vezina C; Balland A
    Biochemistry; 2009 May; 48(17):3755-66. PubMed ID: 19254029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleviating nonlinear behavior of disulfide isoforms in the reversed-phase liquid chromatography of IgG2.
    Cao X; He Y; Smith J; Wirth MJ
    J Chromatogr A; 2015 Sep; 1410():147-53. PubMed ID: 26256919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolving disulfide structural isoforms of IgG2 monoclonal antibodies by ion mobility mass spectrometry.
    Bagal D; Valliere-Douglass JF; Balland A; Schnier PD
    Anal Chem; 2010 Aug; 82(16):6751-5. PubMed ID: 20704363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of antibody subclass and disulfide isoform differences on the biological activity of CD200R and βklotho agonist antibodies.
    Grujic O; Stevens J; Chou RY; Weiszmann JV; Sekirov L; Thomson C; Badh A; Grauer S; Chan B; Graham K; Manchulenko K; Dillon TM; Li Y; Foltz IN
    Biochem Biophys Res Commun; 2017 May; 486(4):985-991. PubMed ID: 28363871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.